Central core myopathy
Central core myopathy (CCM) is a congenital myopathy characterized by muscle weakness and low muscle tone. It is a rare genetic disorder that primarily affects the skeletal muscles, which are used for movement. The condition is named for the characteristic changes seen in muscle cells, specifically the presence of a central core that lacks the normal cellular structures.
Etiology[edit | edit source]
CCM is caused by mutations in the RYR1 gene, which provides instructions for making a protein that plays a key role in muscles used for movement (skeletal muscles). The RYR1 protein is part of a channel that releases calcium ions from storage within cells, an essential step in muscle contraction. Mutations in the RYR1 gene alter the structure or function of these channels, impairing their ability to regulate calcium ion flow and leading to the muscle weakness and other features of CCM.
Symptoms[edit | edit source]
The symptoms of CCM typically appear in infancy or early childhood, although they can also develop later in life. They include muscle weakness, low muscle tone (hypotonia), and delays in motor skills such as sitting, standing, and walking. Some individuals with CCM may also have skeletal abnormalities such as scoliosis (curvature of the spine) or hip dislocation.
Diagnosis[edit | edit source]
Diagnosis of CCM is based on the clinical symptoms, a physical examination, and specialized tests. These tests may include a muscle biopsy, which can reveal the characteristic central cores in muscle cells, and genetic testing, which can identify mutations in the RYR1 gene.
Treatment[edit | edit source]
There is currently no cure for CCM, and treatment is symptomatic and supportive. Physical therapy and occupational therapy may be beneficial for improving muscle strength and mobility. Surgery may be necessary to treat skeletal abnormalities such as scoliosis.
Prognosis[edit | edit source]
The prognosis for individuals with CCM varies. Some individuals have mild symptoms and normal life expectancy, while others may experience severe muscle weakness and related complications.
See also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
